Literature DB >> 20570892

Mitogen-activated protein/extracellular signal-regulated kinase kinase 1act/tubulin interaction is an important determinant of mitotic stability in cultured HT1080 human fibrosarcoma cells.

Jia-Ning Cao1, Norazizah Shafee, Larry Vickery, Stefan Kaluz, Ning Ru, Eric J Stanbridge.   

Abstract

Activation of the mitogen-activated protein kinase (MAPK) pathway plays a major role in neoplastic cell transformation. Using a proteomics approach, we identified alpha tubulin and beta tubulin as proteins that interact with activated MAP/extracellular signal-regulated kinase kinase 1 (MEK1), a central MAPK regulatory kinase. Confocal analysis revealed spatiotemporal control of MEK1-tubulin colocalization that was most prominent in the mitotic spindle apparatus in variant HT1080 human fibrosarcoma cells. Peptide arrays identified the critical role of positively charged amino acids R108, R113, R160, and K157 on the surface of MEK1 for tubulin interaction. Overexpression of activated MEK1 caused defects in spindle arrangement, chromosome segregation, and ploidy. In contrast, chromosome polyploidy was reduced in the presence of an activated MEK1 mutant (R108A, R113A) that disrupted interactions with tubulin. Our findings indicate the importance of signaling by activated MEK1-tubulin in spindle organization and chromosomal instability. (c)2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20570892      PMCID: PMC2938962          DOI: 10.1158/0008-5472.CAN-09-4490

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  41 in total

1.  Structural rearrangements in tubulin following microtubule formation.

Authors:  Angelika Krebs; Kenneth N Goldie; Andreas Hoenger
Journal:  EMBO Rep       Date:  2005-03       Impact factor: 8.807

Review 2.  The ERK cascade: a prototype of MAPK signaling.

Authors:  Hadara Rubinfeld; Rony Seger
Journal:  Mol Biotechnol       Date:  2005-10       Impact factor: 2.695

Review 3.  Centrosome control of the cell cycle.

Authors:  Stephen Doxsey; Wendy Zimmerman; Keith Mikule
Journal:  Trends Cell Biol       Date:  2005-06       Impact factor: 20.808

Review 4.  Microtubule polymerization dynamics.

Authors:  A Desai; T J Mitchison
Journal:  Annu Rev Cell Dev Biol       Date:  1997       Impact factor: 13.827

5.  Mitogen-activated protein kinase kinase activity is required for the G(2)/M transition of the cell cycle in mammalian fibroblasts.

Authors:  J H Wright; E Munar; D R Jameson; P R Andreassen; R L Margolis; R Seger; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

6.  Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta.

Authors:  S Giroux; M Tremblay; D Bernard; J F Cardin-Girard; S Aubry; L Larouche; S Rousseau; J Huot; J Landry; L Jeannotte; J Charron
Journal:  Curr Biol       Date:  1999-04-08       Impact factor: 10.834

7.  Activation of the p42 mitogen-activated protein kinase pathway inhibits Cdc2 activation and entry into M-phase in cycling Xenopus egg extracts.

Authors:  J C Bitangcol; A S Chau; E Stadnick; M J Lohka; B Dicken; E K Shibuya
Journal:  Mol Biol Cell       Date:  1998-02       Impact factor: 4.138

Review 8.  Increasing complexity of Ras signaling.

Authors:  S L Campbell; R Khosravi-Far; K L Rossman; G J Clark; C J Der
Journal:  Oncogene       Date:  1998-09-17       Impact factor: 9.867

9.  Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition.

Authors:  Jeffrey F Ohren; Huifen Chen; Alexander Pavlovsky; Christopher Whitehead; Erli Zhang; Peter Kuffa; Chunhong Yan; Patrick McConnell; Cindy Spessard; Craig Banotai; W Thomas Mueller; Amy Delaney; Charles Omer; Judith Sebolt-Leopold; David T Dudley; Iris K Leung; Cathlin Flamme; Joseph Warmus; Michael Kaufman; Stephen Barrett; Haile Tecle; Charles A Hasemann
Journal:  Nat Struct Mol Biol       Date:  2004-11-14       Impact factor: 15.369

10.  Activation of the MKK/ERK pathway during somatic cell mitosis: direct interactions of active ERK with kinetochores and regulation of the mitotic 3F3/2 phosphoantigen.

Authors:  P S Shapiro; E Vaisberg; A J Hunt; N S Tolwinski; A M Whalen; J R McIntosh; N G Ahn
Journal:  J Cell Biol       Date:  1998-09-21       Impact factor: 10.539

View more
  6 in total

1.  Divergent Polypharmacology-Driven Cellular Activity of Structurally Similar Multi-Kinase Inhibitors through Cumulative Effects on Individual Targets.

Authors:  Natalia J Sumi; Claudia Ctortecka; Qianqian Hu; Annamarie T Bryant; Bin Fang; Lily L Remsing Rix; Muhammad Ayaz; Fumi Kinose; Eric A Welsh; Steven A Eschrich; Harshani R Lawrence; John M Koomen; Eric B Haura; Uwe Rix
Journal:  Cell Chem Biol       Date:  2019-06-27       Impact factor: 8.116

2.  Type 10 soluble adenylyl cyclase is overexpressed in prostate carcinoma and controls proliferation of prostate cancer cells.

Authors:  Jan-Paul Flacke; Hanna Flacke; Avinash Appukuttan; Rein-Jüri Palisaar; Joachim Noldus; Brian D Robinson; H Peter Reusch; Jonathan H Zippin; Yury Ladilov
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

Review 3.  Targeting Adenylate Cyclase Family: New Concept of Targeted Cancer Therapy.

Authors:  Rui Guo; Tian Liu; Marzieh Dehghan Shasaltaneh; Xuan Wang; Saber Imani; QingLian Wen
Journal:  Front Oncol       Date:  2022-06-27       Impact factor: 5.738

4.  NAD(P)H:quinone oxidoreductase 1 (NQO1) localizes to the mitotic spindle in human cells.

Authors:  David Siegel; Jadwiga K Kepa; David Ross
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

5.  Spatiotemporal control of pathway sensors and cross-pathway feedback regulate a differentiation MAPK pathway in yeast.

Authors:  Aditi Prabhakar; Beatriz González; Heather Dionne; Sukanya Basu; Paul J Cullen
Journal:  J Cell Sci       Date:  2021-08-04       Impact factor: 5.235

Review 6.  Kinome profiling.

Authors:  Maikel P Peppelenbosch
Journal:  Scientifica (Cairo)       Date:  2012-08-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.